Maternal diabetes modulates renal morphogenesis in offspring

Journal of the American Society of Nephrology

Volumn 19, Issue 5, 2008, Pages 943-952

  Tran, Stella ^a   Chen, Yun Wen ^a   Chenier, Isabelle ^a   Chan, John S D ^a   Quaggin, Susan ^b   Hébert, Marie Josée ^a   Ingelfinger, Julie R ^c   Zhang, Shao Ling ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; CASPASE 3; GREEN FLUORESCENT PROTEIN; HOX PROTEIN; HOXB7 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RENIN; STREPTOZOCIN; HOMEODOMAIN PROTEIN; HOXB7 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY SIZE; BODY WEIGHT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY ANOMALY; KIDNEY DEVELOPMENT; KIDNEY MASS; KIDNEY TUBULE; MATERNAL DIABETES MELLITUS; MOUSE; NEPHRON; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; ANIMAL; CONGENITAL MALFORMATION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; KIDNEY; METABOLISM; NEWBORN; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BODY WEIGHT; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; DIABETES, GESTATIONAL; FEMALE; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; KIDNEY; MICE; MICE, TRANSGENIC; NEPHRONS; NF-KAPPA B; ORGAN SIZE; PODOCYTES; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 44049090093     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007080864     Document Type: Article

References (75)

1. Holemans K, Aerts L, Van Assche FA: Fetal growth and long-term consequences in animal models of growth retardation. Eur J Obstet Gynecol Reprod Biol 81: 149-156, 1998
2. Holemans K, Gerber RT, Meurrens K, De Clerck F, Poston L, Van Assche FA: Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia 42: 81-89, 1999
3. Holemans K, Caluwaerts S, Van Assche FA: Unravelling the fetal origins hypothesis. Lancet 360: 2073-2075, 2002
4. Holemans K, Aerts L, Van Assche FA: Fetal growth restriction and consequences for the offspring in animal models. J Soc Gynecol Investig 10: 392-399, 2003
5. Holemans K, Aerts L, Van Assche FA: Lifetime consequences of abnormal fetal pancreatic development. J Physiol 547: 11-20, 2003
6. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes: Glycemic control prevents congenital anomalies. JAMA 265: 731-736, 1991
7. Lynch SA, Wright C: Sirenomelia, limb reduction defects, cardiovascular malformation, renal agenesis in an infant born to a diabetic mother. Clin Dysmorphol 6: 75-80, 1997
8. Soler NG, Walsh CH, Malins JM: Congenital malformations in infants of diabetic mothers. Q J Med 45: 303-313, 1976
9. Woolf AS: Multiple causes of human kidney malformations. Arch Intern Med 77: 471-473, 1997
10. Zandi-Nejad K, Luyckx VA, Brenner BM: Adult hypertension and kidney disease: The role of fetal programming. Hypertension 47: 502-508, 2006
11. Manning J, Vehaskari VM: Low birth weight-associated adult hypertension in the rat. Pediatr Nephrol 16: 417-422, 2001
12. Mercurio F, Manning AM: NF-kappaB as a primary regulator of the stress response. Oncogene 18: 6163-6171, 1999
13. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP: The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10: 157-167, 1999
14. Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Palu-dan SR, Rasch R: Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 53: 166-172, 2004
15. Morcos M, Sayed AA, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Abd el Baki RF, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt AM, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP: Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51: 3532-3544, 2002
16. Starkey JM, Haidacher SJ, LeJeune WS, Zhang X, Tieu BC, Choudhary S, Brasier AR, Denner LA, Tilton RG: Diabetes-induced activation of canonical and noncanonical nuclear factor-kappaB pathways in renal cortex. Diabetes 55: 1252-1259, 2006
17. Perkins ND, Gilmore TD: Good cop, bad cop: The different faces of NF-kappaB. Cell Death Differ 13: 759-772, 2006
18. Janssen I, Katzmarzyk PT, Boyce WF, King MA, Pickett W: Overweight and obesity in Canadian adolescents and their associations with dietary habits and physical activity patterns. J Adolesc Health 35: 360-367, 2004
19. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C: Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25: 6800-6816, 2006
20. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K: Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 13: 730-737, 2006
21. Xue X, Piao JH, Nakajima A, Sakon-Komazawa S, Kojima Y, Mori K, Yagita H, Okumura K, Harding H, Nakano H: Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. J Biol Chem 280: 33917-33925, 2005
22. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50: 2792-2808, 2001
23. Lee FT, Cao Z, Long DM, Panagiotopoulos S, Jerums G, Cooper ME, Forbes JM: Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol 15: 2139-2151, 2004
24. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I: Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 272: F299-F304, 1997
25. Okubo S, Niimura F, Matsusaka T, Fogo A, Hogan BL, Ichikawa I: Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney Int 53: 617-625, 1998
26. Matsusaka T, Kon V, Takaya J, Katori H, Chen X, Miyazaki J, Homma T, Fogo A, Ichikawa I: Dual renin gene targeting by Cre-mediated interchromosomal recombination. Genomics 64: 127-131, 2000
27. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I: Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin invest 101: 755-760, 1998
28. Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA III, Hogan BM, Fogo A, Brock JW III, Inagami T, Ichikawa I: Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3: 1-10, 1999
29. Chen Y, Lasaitiene D, Friberg P: The renin-angiotensin system in kidney development. Acta Physiol Scand 181: 529-535, 2004
30. Ingelfinger JR, Woods LL: Perinatal programming, renal development, and adult renal function. Am J Hypertens 15: 46S-49S, 2002
31. Iosipiv IV, Schroeder M: A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol Renal Physiol 285: F199-F207, 2003
32. Moritz KM, Dodic M, Wintour EM: Kidney development and the fetal programming of adult disease. Bioessays 25: 212-220, 2003
33. Pan L, Gross KW: Transcriptional regulation of renin: An update. Hypertension 45: 3-8, 2005
34. Solhaug MJ, Bolger PM, Jose PA: The developing kidney and environmental toxins. Pediatrics 113: 1084-1091, 2004
35. Wolf G: Angiotensin II and tubular development. Nephrol Dial Transplant 17[Suppl 9]: 48-51, 2002
36. Zhang SL, Moini B, Ingelfinger JR: Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. J Am Soc Nephrol 15: 1452-1465, 2004
37. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS: High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143: 2975-2985, 2002
38. Hsieh TJ, Fustier P, Wei CC, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS: Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol 183: 535-550, 2004
39. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Quo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS: RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69: 1016-1023, 2006
40. Zhang SL, Chen X, Wei CC, Filep JG, Tang SS, Ingelfinger JR, Chan JS: Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. Endocrinology 143: 4627-4635, 2002
41. Brenner BM, Garcia DL, Andersen S: Glomeruli and blood pressure: Less of one, more the other? Am J Hypertens 1: 335-347, 1988
42. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63: S124-S127, 1997
43. Mackenzie HS, Brenner BM: Fewer nephrons at birth: A missing link in the etiology of essential hypertension? Am J Kidney Dis 26: 91-98, 1995
44. Mackenzie HS, Lawler EV, Brenner BM: Congenital oligonephropathy: The fetal flaw in essential hypertension? Kidney Int Suppl 55: S30-S34, 1996
45. Chi MM, Pingsterhaus J, Carayannopoulos M, Moley KH: Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst 12. J Biol Chem 275:40252-40257, 2000
46. Keim AL, Chi MM, Moley KH: Hyperglycemia-induced apoptotic cell death in the mouse blastocyst is dependent on expression of p53 10. Mol Reprod Dev 60: 214-224, 2001
47. Leunda-Casi A, Genicot G, Donnay I, Pampfer S, De Hertogh R: Increased cell death in mouse blastocysts exposed to high D-glucose in vitro: implications of an oxidative stress and alterations in glucose metabolism 4. Diabetologia 45: 571-579, 2002
48. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM: Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways 14. Nat Med 4: 1421-1424, 1998
49. Pampfer S, Donnay I: Apoptosis at the time of embryo implantation in mouse and rat 19. Cell Death Differ 6: 533-545, 1999
50. Pampfer S, Cordi S, Vanderheyden I, Van Der Smissen P, Courtoy PJ, Van Cauwenberge A, Alexandre H, Donnay I, De Hertogh R: Expression and role of Bcl-2 in rat blastocysts exposed to high D-glucose 11. Diabetes 50: 143-149,2001
51. Ekblom P, Miettinen A, Virtanen I, Wahlstrom T, Dawnay A, Saxen L: In vitro segregation of the metanephric nephron 4. Dev Biol 84: 88-95, 1981
52. Piscione TD, Rosenblum ND: The molecular control of renal branching morphogenesis: Current knowledge and emerging insights 3. Differentiation 70: 227-246, 2002
53. Chen YW, Liu F, Tran S, Zhu Y, Hebert MJ, Ingelfinger JR, Zhang SL: Reactive oxygen species and nuclear factor-kappa B pathway mediate high glucose-induced Pax-2 gene expression in mouse embryonic mesenchymal epithelial cells and kidney expiants. Kidney Int 70: 1607-1615, 2006
54. Kumar D, Robertson S, Burns KD: Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem 259: 67-70, 2004
55. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JS: Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 71: 912-923, 2007
56. Sequeira Lopez ML, Pentz ES, Robert B, Abrahamson DR, Gomez RA: Embryonic origin and lineage of juxtaglomerular cells. Am J Physiol Renal Physiol 281: F345-F356, 2001
57. Carey RM, McGrath HE, Pentz ES, Gomez RA, Barrett PQ: Biomechanical coupling in renin-releasing cells. J Clin Invest 100: 1566-1574, 1997
58. Gomez RA, Tufro-McReddie A, Norwood VF, Harris M, Pentz ES: Renin-angiotensin system: Kidney growth and development. Exp Nephrol 2: 130, 1994
59. Mezzano S, Droguett A, Burgos ME, Ardiles LG, Flores CA, Aros CA, Caorsi I, Vio CP, Ruiz-Ortega M, Egido J: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl S64-S70, 2003
60. Srinivas S, Goldberg MR, Watanabe T, D'Agati V, al-Awqati Q, Costantini F: Expression of green fluorescent protein in the ureteric bud of transgenic mice: A new tool for the analysis of ureteric bud morphogenesis. Dev Genet 24: 241-251, 1999
61. Watanabe T, Costantini F: Real-time analysis of ureteric bud branching morphogenesis in vitro. Dev Biol 271: 98-108, 2004
62. Cui S, Li C, Ema M, Weinstein J, Quaggin SE: Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout mice. J Am Soc Nephrol 16: 3247-3255, 2005
63. Zhang SL, Chen YW, Tran S, Chenier I, Hebert MJ, Ingelfinger JR: Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 18: 2105-2115, 2007
64. Cuezva JM, Burkett ES, Kerr DS, Rodman HM, Patel MS: The newborn of diabetic rat. I. Hormonal and metabolic changes in the postnatal period. Pediatr Res 16: 632-637, 1982
65. Kanwar YS, Akagi S, Nayak B, Sun L, Wada J, Xie P, Thakur A, Chugh SS, Danesh FR: Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development. Kidney Int 68: 1670-1683, 2005
66. Eriksson U, Andersson A, Efendic S, Elde R, Hellerstrom C: Diabetes in pregnancy: Effects on the foetal and newborn rat with particular regard to body weight, serum insulin concentration and pancreatic contents of insulin, glucagon and somatostatin. Acta Endocrinol (Copenh) 94: 354-364, 1980
67. Oh W, Gelardi NL, Cha CJ: Maternal hyperglycemia in pregnant rats: Its effect on growth and carbohydrate metabolism in the offspring. Metabolism 37: 1146-1151, 1988
68. Kervran A, Guillaume M, Jost A: The endocrine pancreas of the fetus from diabetic pregnant rat. Diabetologia 15: 387-393, 1978
69. Aerts L, Sodoyez-Goffaux F, Sodoyez JC, Malaisse WJ, Van Assche FA: The diabetic intrauterine milieu has a long-lasting effect on insulin secretion by B cells and on insulin uptake by target tissues. Am J Obstet Gynecol 159: 1287-1292, 1988
70. Oh W, Gelardi NL, Cha CJ: The cross-generation effect of neonatal macrosomia in rat pups of streptozotocin-induced diabetes. Pediatr Res 29: 606-610, 1991
71. Weibel ER, ed.: Numerical density: Shape and size of particles. In: Stereological Methods, Vol. 2 Theoretical Foundations, London, Academic Press, 1980, pp 149-152
72. Bertram JF: Counting in the kidney. Kidney Int 59: 792-796, 2001
73. Brezniceanu ML, Wei CC, Zhang SL, Hsieh TJ, Guo DF, Hebert MJ, Ingelfinger JR, Filep JG, Chan JS: Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells. Kidney Int 69: 1977-1985, 2006
74. Chen X, Zhang SL, Pang L, Filep JG, Tang SS, Ingelfinger JR, Chan JS: Characterization of a putative insulin-responsive element and its binding protein(s) in rat angiotensinogen gene promoter: Regulation by glucose and insulin. Endocrinology 142: 2577-2585, 2001
75. Wei CC, Guo DF, Zhang SL, Ingelfinger JR, Chan JS: Heterogenous nuclear ribonucleoprotein F modulates angiotensinogen gene expression in rat kidney proximal tubular cells. J Am Soc Nephrol 16: 616-628, 2005